Gout can lead to permanent joint damage, kidney stones, kidney disease, and a significantly higher risk of heart attack and stroke. What starts as occasional painful flares can, over years of elevated uric acid, cause problems that reach well beyond your joints. The complications depend largely on how long uric acid levels stay high and whether the condition is managed effectively.
Permanent Joint and Bone Damage
The most direct consequence of uncontrolled gout is structural damage to your joints. Uric acid crystals don’t just cause inflammation during flares. Over time, they form solid deposits called tophi that press into bone, cartilage, and tendons. These tophi act like slow-growing invaders, gradually eroding the bone beneath them. X-rays of advanced gout show characteristic “punched out” erosions with overhanging edges, where the bone has tried and failed to grow around the expanding deposit. These erosions typically don’t appear on imaging until 6 to 12 years after the first acute attack, which is why gout can seem harmless for years before the damage becomes visible.
The progression follows a rough pattern. Early gout involves isolated flares with pain-free periods in between. Without treatment, flares become more frequent, affect more joints, and eventually the pain becomes near-constant. This final stage, tophaceous gout, usually takes many years of uncontrolled disease to develop. At that point, tophi may be visible under the skin around joints, on the ears, or near the elbows. In some cases, tophi break through the skin, releasing a chalky white discharge and leaving open sores that are slow to heal and vulnerable to infection. In rare cases, a tophus can compress a nerve or interfere with organ function.
Kidney Stones and Kidney Disease
Your kidneys are responsible for clearing uric acid from your blood, which makes them especially vulnerable when levels stay high. About half of people with gout develop pure uric acid kidney stones, a rate far higher than the general population. These stones form when uric acid crystallizes in concentrated, acidic urine.
Beyond stones, persistently elevated uric acid can damage the kidneys directly. A condition called chronic gouty nephropathy occurs when urate crystals deposit in the inner tissue of the kidney, triggering inflammation and scarring. This process is slow and often painless, which means kidney function can decline significantly before you notice symptoms. People with gout who also have high blood pressure are at particular risk, since hypertension accelerates kidney damage from any cause.
Heart Attack and Stroke Risk
Gout is tied to a meaningfully higher risk of cardiovascular disease. The Rotterdam Study, a large population-based study, found that people with the highest uric acid levels had an 87% greater risk of heart attack and a 57% greater risk of stroke compared to those with the lowest levels. For ischemic stroke specifically (the type caused by a blocked blood vessel in the brain), the risk was 77% higher.
The connection likely involves multiple pathways. Chronic inflammation from repeated gout flares can damage blood vessel walls. High uric acid itself appears to promote stiffening of the arteries and oxidative stress. And gout frequently coexists with other cardiovascular risk factors like obesity, high blood pressure, and insulin resistance, creating a compounding effect.
Type 2 Diabetes
People with gout are substantially more likely to develop type 2 diabetes. A large study tracking nearly 30,000 gout patients and 60,000 matched controls over more than a decade found that gout increased diabetes risk by 70% overall. The association was even stronger in women, who faced roughly double the risk of their non-gout counterparts. About 13% of gout patients in the study developed type 2 diabetes during follow-up, compared to about 11% of controls. The relationship held even after accounting for other risk factors, suggesting gout itself, or the metabolic dysfunction driving it, plays an independent role.
Depression and Anxiety
Living with gout takes a psychological toll that often goes unrecognized. A meta-analysis pooling data from multiple studies found that gout patients had 29% higher odds of depression compared to people without the condition. The number of tophi, the frequency of flares, and whether gout affected multiple joints were all significant predictors of depression. This makes intuitive sense: unpredictable, debilitating pain that disrupts sleep, work, and mobility wears people down over time. The anxiety of not knowing when the next flare will hit adds another layer of stress.
Sleep Apnea and Gout
Obstructive sleep apnea and gout frequently occur together. People with sleep apnea tend to have higher uric acid levels, and genetic analysis confirms that sleep apnea causally raises uric acid in the blood. The mechanism likely involves repeated drops in oxygen during sleep, which increases the body’s production of uric acid as a byproduct of cellular stress. While the link between sleep apnea and gout risk may be partly explained by shared factors like obesity and diabetes, the effect on uric acid levels appears to be direct. If you have gout and also snore heavily, wake up tired, or experience daytime sleepiness, getting evaluated for sleep apnea could be an important part of managing your uric acid.
Rare but Serious Complications
Uric acid crystals can deposit in places far removed from the typical big toe joint. Documented locations include the colon, nasal bridge, tongue, larynx, vocal cords, and heart valves. Eye involvement is more common than most people realize. Crystal deposits have been found in the cornea, iris, and the white of the eye, and gout has been linked to inflammation inside the eye, increased eye pressure, and blurred disc margins. One case report described crystal-like lesions in the macula of a patient with uncontrolled gout.
Spinal involvement, while rare, can be particularly dangerous. Urate deposits in the spine have caused spinal cord compression in a number of documented patients. These unusual complications tend to occur in people with long-standing, poorly controlled disease and very high uric acid levels. They underscore that gout is a systemic condition, not just a joint problem.